Chengdu Bright Eye Hospital Co., Ltd.'s (SZSE:301239) Market Cap Increased by CN¥372m, Insiders Receive a 44% Cut

Simply Wall StJul 17 19:57 ET

Purui Ophthalmology (301239.SZ) plans to distribute 4 yuan per 10 shares, ex-dividend on July 22.

PRK Eye Care (301239.SZ) announced that the annual equity distribution for 2023 is planned to be 10 shares for every shareholder...

Zhitong FinanceJul 15 06:33 ET

Is Chengdu Bright Eye Hospital (SZSE:301239) A Risky Investment?

Simply Wall StJun 9 22:15 ET

Prui Ophthalmology (301239.SZ) released 6.65% of the company's shares held by the controlling shareholder.

PRIME Vision (Stock Code: 301239.SZ) has released an announcement that the controlling shareholder of the company, Chengdu Prime Century Investment Co., Ltd. (...)

Zhitong FinanceJun 6 05:05 ET

Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Simply Wall StMay 13 21:02 ET

Gelonghui announcement selection | Puri Ophthalmology: Net profit in 2023 increased 1202.56% year-on-year, and plans to pay 10 to 4 yuan; Jie'an Hi-Tech: The company's military virtual simulation training products account for a small share of the company'

[Contract won] Zhonglai Co., Ltd. (300393.SZ): The consortium won the bid for 2,756 billion yuan household photovoltaic-related project, Zhonglai Shares (300393.SZ) announced that the company's holding subsidiary Suzhou Zhonglai Minsheng Energy Co., Ltd. (“Zhonglai Minsheng”) and its wholly-owned subsidiary Zhonglai Zhilian Energy Engineering Co., Ltd. (“Zhonglai Zhilian”) consortium previously won the bid for the “Zhejiang Zhejiang Energy Service Co., Ltd. Second Batch Household Photovoltaic Project Engineering General Contracting (EPC) Framework Agreement Procurement Project”. The “Winning Bid “Notice”, the winning bid price was 27

Gelonghui FinanceApr 23 11:49 ET